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Abstract: 
One approach for the synthesis of isoindolinones, a privileged bioactive heterocyclic core 
structure, involves a condensation reaction of o-phthaldialdehydes with a suitable nitrogen-
containing nucleophile. This fascinating reaction is revisited here in the context of the use of 
o-phthaldialdehydes that contain additional substituents in the aromatic ring leading to a 
detailed analysis of the regioselectivity of the reaction. Eleven monosubstituted o-
phthaldialdehydes were synthesised and reacted with alanine. The regioselectivity observed 
across the eleven substrates led to the design of a disubstituted substrate that reacted with 
very high control. A gram-scale reaction followed by esterification gave one major 
regioisomer in high yield. In addition, the regioselectivity observed on reaction of two novel 
monodeuterated substrates led to an increased mechanistic understanding. 
  
                                                 
∗ Corresponding author. Tel.: +44-1334-46-3816; fax: +44-1334-46-2595; e-mail: njw3@st-andrews.ac.uk 
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1. Introduction 
The isoindolinones make up an important class of bioactive molecules that includes the 
known drugs Pazinaclone (1),1a Indoprofen (2)1b and Chlorthalidone (3)1c (Figure 1a). 
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Figure 1: a) Structure of known bioactive isoindolinone containing drugs;1 b) Overview of 
some of the different routes used to prepare the isoindolinone core 4.2-6a 
 
Common methods of obtaining isoindolinones that are unsubstituted in the aromatic ring, for 
example compound 4 (Figure 1b), include selective reduction of 5,2 reductive amination-
cyclisation of 63 or 74 with a primary amine (RNH2) and, of interest here, the condensation 
reaction of o-phthaldialdehyde (8) with a primary amine (RNH2).5,6a 
To date, the majority of studies performed on this condensation reaction have focused on 
evaluating the scope of the amine nucleophile that can be tolerated in the reaction5a,5b,5d,6a,6b 
and/or proposing potential reaction mechanisms.5a,5b,6 In contrast, examples of the use of this 
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condensation reaction with monosubstituted o-phthaldialdehydes are rare (SI1 part I). One 
report describes a regioselectivity of 1:1 for the products 11:12 resulting from the 
condensation of 9 with 10 (Scheme 1a).7 However, the observed regioselectivity was 
measured only after filtration or purification by column chromatography. Isolated yields for 
the formation of a single isomer, 14 in most cases, resulting from the condensation of 13 with 
various amines have also been reported (Scheme 1b).8 Other studies have provided only 
isolated yield(s) after purification (for one or for each isomer), incomplete regioisomeric ratio 
(rr) data within a series or have claimed to form a single regioisomer (no yield provided) 
without discussing the other possible isomer (SI1 part I).7-9 
The work reported here revisits this issue by presenting a detailed study of the regiochemical 
outcome of the condensation of alanine (16) with 3-monosubstituted o-phthaldialdehydes 17 
(to give 18 and 19, Scheme 1c) and with 4-monosubstituted o-phthaldialdehydes 20 (to give 
21 and 22, Scheme 1d). Based on the initial results, the design of a highly regioselective 
substrate was achieved consistent with an improved understanding of the reaction. Further 
mechanistic insights were provided by the use of novel mono-deuterated substrates. 
 
<<Single column scheme>> 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 6
 
 
Scheme 1: a) and b) eported in the literature.7-8 Apparently no regioselectivity was observed 
for the condensation of 9 with 10 (ratio of 11:12 of 1:1 obtained after filtration (for R=F, Cl) 
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or after purification of the crude reaction mixture by column chromatography (for R=SMe)).7 
Condensation of 13 with various amines (RNH2) followed by purification by column 
chromatography mainly led to isomer 14 (no comment was made regarding the apparent 
change of regioselectivity to give isomer 15 as the major isomer in one case).8 c) and d) A 
summary of the study reported in this work to explore in more detail the influence of a 
substituent at the 3- or 4-position of the starting o-phthaldialdehyde on the observed 
regioselectivity. 
 
2. Results and Discussions 
2.1. Synthesis of Monosubstituted o-Phthaldialdehydes 
Five 3-substituted o-phthaldialdehydes 17a-e were synthesised using 2-5 step routes 
involving either a Swern oxidation of the corresponding diol 23 or an acetal deprotection of 
the corresponding monoacetal 24 or diacetal 25 (Scheme 2 and SI1 part II.1 for more details). 
It should be noted that the synthesis of pure samples of 17a-e was particularly challenging (in 
line with literature reports10) with significant decomposition occurring during purification 
attempts and on storage. In several cases freshly prepared crude samples of the dialdehydes 
were used (Table 1, footnote c). Additionally, six 4-monosubstituted o-phthaldialdehydes 
20a-f were synthesised using 2-3 step routes either involving a Swern oxidation of the 
corresponding diol 26 or an acetal deprotection of the corresponding monoacetal 24 (Scheme 
2 and SI1 part II.2 for more details). 
 
<<single column scheme>> 
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Scheme 2: a) General synthesis scheme describing the approaches used to prepare mono-
substituted o-phthaldialdehydes 17 or 20. 17 and 20 were synthesised by Swern oxidation of 
23 or 26, or by acetal deprotection of 24 or 25; b) Structures of the monosubstituted o-
phthaldialdehyde substrates 17 and 20 synthesised in this study. 
 
2.2 Regioselectivity of the Condensation Reaction of Mono-substituted o-Phthaldialdehydes 
The mono-substituted o-phthaldialdehydes 17a-e and 20a-f were refluxed for 4 h with alanine 
(16, 1.2 equivalents) in anhydrous acetonitrile before the reaction was concentrated in vacuo. 
The crude reaction mixtures (except when specified, Table 1) were then analysed using a 
quantitative 1H NMR experiment. A baseline correction was applied using MestReNova-9 
software and integrations were calculated relative to one proton on deconvoluted peaks (see 
Figure 2 for an example of the analysis applied to the formation of 18a/19a and SI1 part III.1 
for the rest of the NMR analysis; also see the experimental section below for a detailed 
explanation of the analytical protocol used).  
In two of the condensation reactions the structure of the major regioisomer was identified by 
comparison with the 1H NMR spectrum of a pure sample of one of the regioisomers (for 
18a/19a, 21a/22a, for the synthesis of authentic isomers see SI1 part III.2). In the rest of the 
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cases, advanced NMR techniques (HSQC, HMBC, COSY) applied to the crude reaction 
mixture were used to assign the structure of the major regioisomer. Considering the analysis 
of the regioisomeric mixture of 18b/19b as an example (Figure 3), the proximity of a 
carbonyl was observed to shift the signal corresponding to the aromatic H7 proton in 18b and 
the methyl H1’ protons in 19b downfield (Figures 3a and 3b). Identification of H7 in 18b was 
further validated by its correlation with C1 in the HMBC analysis of the regioisomeric 
mixture (Figure 3a). In contrast, H4 in 19b showed a correlation with C3 in this HMBC 
analysis (Figure 3c). Using the correlations observed in the COSY spectrum (Figure 3d), the 
signals corresponding to H5 and H6 for 18b and 19b were finally assigned. The value of the 
integrals in the 1D quantitative 1H NMR spectra enabled the identification of 18b as major 
isomer.  
Having assigned the signals corresponding to the two regioisomeric products in each case, 
and using as many peaks as possible, an average percentage of the major isomer with its 95% 
confidence interval was then calculated for each reaction (SI1 part III.3). The reaction and its 
analysis were also carried out in duplicate for each substrate demonstrating high 
reproducibility (SI1 part III.3). 
 
<< double column width >> 
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Figure 2: Quantitative 1H NMR spectra of the product mixture containing 18a and 19a 
formed on reaction of 17a with alanine (16) (Table 1 entry 1). From left to right the spectra 
represent the aromatic, the methoxy and the alanine methyl protons. Overlap between the 
other signals corresponding to 18a and 19a prevented the use of the other proton signals in 
the calculations. The integrals and assignments considered for the calculation of the average 
percentage of the major regioisomer with its 95% confidence interval (and therefore the 
regioisomeric ratio, see Table 1) are shown here. The top spectra represent the first 
experiment and the spectra at the bottom represent the repeat reaction. 
 
<< double column width >> 
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Figure 3: NMR data used to identify the structure of the major isomer in the mixture of 18b 
and 19b regioisomers. H7 in 18b was identified by its downfield shift, due to the 
neighbouring carbonyl group, and its correlation to C1 in the HMBC spectrum mixture 
(spectrum A). H1’ from 19b was identified by its downfield shift in the 1H NMR spectrum 
due to the neighbouring carbonyl group (spectrum B). H4 from 19b was identified by its 
correlation to C3 in the HMBC spectrum of the regioisomeric mixture (spectrum C). Starting 
with H4 from 19b, the correlations observed in the COSY spectrum (spectrum D) identified 
H5 (arrow 1) then H6 (arrow 2). Similarly, the correlations observed in the COSY spectrum 
for H7 from 18b led to the identification H5 and H6 (arrow 3). 
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<<single column>> 
Table 1: Condensation reaction of monosubstituted o-phthaldialdehydes 17 or 20. 
                       
Substrate Products ; regioisomeric ratio (rr)a Yieldb
 
(%)
3-substituted series 
 
 
78% 
H
O
H
O
17bc   
49%d 
 
 
11%f 
 
 
33%d 
 
 
60% 
4-substituted series 
 
 
90% 
  
93% 
 
 
90% 
 
 
73% 
 
 
55%d 
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35%d 
 
a based on analysis of crude reaction before purification (SI1 part III.3). b isolated yield of the 
mixture of the two inseparable regioisomers. c crude dialdehyde was used. d extrapolated yield 
over two steps. e a significant amount of impurities in the crude reaction mixture led to an 
inaccurate determination of rr (57:43 – 60:40, SI1 part III.1). The rr is reported after 
purification by chromatography with collection of as much product as possible. f the batch of 
dialdehyde 17c was divided into two portions to carry out the duplicate reactions. The 
resulting products were combined to give a yield over two steps. 
 
In both the 3- and 4-substituted series, the regioselectivity of the condensation reaction was 
dependent on the substituent employed, as expected. In the 3-substituted series, the presence 
of either an electron-donating or an electron-withdrawing substituent favoured the formation 
of regioisomer 18 although a decrease in the electron-donating strength led to a clear decrease 
in the regioselectivity. In the 4-substituted series it was observed that as the electron-donating 
properties of the substituent decreased (OMe > F/Br/Me > CF3 > NO2), the regioselectivity 
decreased and then switched from 21 being the major isomer to its regioisomer 22 being the 
dominant product. In both series, the methoxy substituent gave the highest regioselectivity 
leading to the proposal that a dimethoxysubstituted o-phthaldialdehyde 27 (Scheme 3) should 
react with very high regioselectivity. 
 
2.3 Dimethoxysubstituted o-Phthaldialdehyde 
As the monomethoxysubstituted substrates 17a and 20a led to the major regioisomers 18a 
and 21a respectively, it was proposed that a 3,5-dimethoxysubstituted dialdehyde 27 would 
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react to give 28 with an increased regioselectivity compared to 17a and 20a (Scheme 3). A 6-
step route was developed to obtain 27 (SI1 part IV.1) and pleasingly, its subsequent reaction 
with alanine (16) gave 28 as the major regioisomer in a 88:12 ratio of 28:29 (Scheme 3 and 
SI1 part IV.2).  
 
<<single column>> 
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Scheme 3: Rationale behind the design of substrate 27, a 3,5-dimethoxysubstituted o-
phthaldialdehyde expected to favour the regioisomer 28 with a high regioselectivity. 
Reagents and conditions: a) alanine (16), anhyd. MeCN, reflux, 4 h, 93% yield of 28:29 with 
rr 88:12 (from 0.03 g of 27), 90% yield of 28 and 29 (1.2 g, from 0.97 g of 27); (b) alanine 
(16), anhyd. MeCN, rt, 29 h, quant. yield of 28:29 with rr 97:3 (from 0.03 g of 27); (c) 
SOCl2, anhyd. MeOH, rt, 12 h, 84% (1.06 g) for 30, 16% (0.20 g) for 31. 
 
 
On scaling up the condensation reaction of 27 (0.97 g instead of 30 mg initially used), the 
quantitative 1H NMR analysis of the crude reaction mixture was not carried out in this case 
due to the low solubility of the isoindolinone products requiring a large amount of deuterated 
solvent for their complete dissolution (Scheme 3). Purification by column chromatography 
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led to the pure and inseparable regioisomers 28 and 29 in good yield (90%, 1.2 g). 
Derivatisation using thionyl chloride and methanol gave the now separable regioisomeric 
esters isolated in 1.06 g for ester 30 (84% yield) and 0.2 gram for ester 31 (16% yield) 
respectively. The overall esterification yield was quantitative and thus the initial ratio of 28 
and 29 for the larger scale was calculated as 84:16 which was comparable to the small scale 
result (88:12 of 28:29). Inspired by this result, the condensation reaction was attempted on a 
small scale (30 mg of 27) at room temperature (as opposed to reflux) and led to an excellent 
regioselectivity of 97:3 of 28:29 (Scheme 3 and SI1 part IV.3). 
 
2.4 Mechanism Discussion 
A continuing discussion on the likely mechanism of this condensation reaction has occurred 
in the literature over the last decade.5-6 The early stages of the proposed mechanisms can be 
divided into two categories involving either an isoindolinediol intermediate5 (such as 32 from 
20a) or imine intermediates6 (such as 33 and 34 from 20a) (Scheme 4). 
 
<<single column>> 
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Scheme 4: Considering the two most frequently proposed mechanisms in the literature5-6: (i) 
if the reaction proceeds via 32, the electron-donating properties of the methoxy-substituent 
should favour the displacement of the C1-hydroxyl in 32, leading to the major isomer 21a (as 
observed) or (ii) if the reaction proceeds via 33 and 34, the electron-donating properties of the 
methoxy-substituent should decrease the reactivity of the C1-formyl in 20a, favouring 34 and 
leading to 22a as the major product (not observed). 
 
Whilst drawing clear mechanistic conclusion from the 3-monosubstituted o-phthaldialdehyde 
series proved challenging (see SI1 part V.1. for a more detailed discussion), the results 
obtained with the 4-substituted series proved insightful (Table 1). Considering 20a as an 
example (Scheme 4), the electron-donating properties of the methoxy-substituent should 
favour the displacement of the C1-hydroxyl group in the proposed isoindolinediol 
intermediate 32 leading to the predicted formation of regioisomer 21a as the major product 
(as observed, see Table 1). In contrast, the electron-donating properties of the methoxy-
substituent would be expected to decrease the reactivity of the C1-formyl group11 in 20a 
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favouring the formation of the proposed imine intermediate 34 over imine 33 and therefore 
predicting that 22a should be the major product (not observed). In this study, 21a was 
obtained as the major regioisomer providing evidence to support the initial conversion of 20a 
to the isoindolinediol intermediate 32. The same reasoning could explain the switch for the 
formation of the regioisomer 22e as the major product when the strongly electron-
withdrawing nitro-substituent was used (substrate 20e, Table 1 and SI1 part V.2 for a more 
detailed discussion). This conclusion is also supported by Pan et al. and Jones et al.’s studies 
reporting the ESI-MS² and the 1H NMR spectroscopy detection of an isoindolinediol 
intermediate in a related transformation.5a, 5b 
Assuming an isoindolinediol intermediate is initially formed in this reaction, two routes have 
been proposed in the literature to form the final isoindolinones.5a,5c,5e,5f One of these involving 
a [1,3]-hydride shift was ruled out based on stereoelectronic arguments (see reference 5(f) for 
additional comment). Detailed consideration of the other possible mechanism and inspired by 
the reaction of the mono-substituted o-phthaldialdehyde 17a, it was proposed that the use of a 
mono-deuterated mono-methoxysubstituted substrate such as 35 (Scheme 5) could potentially 
provide additional mechanistic information. If the proposed reaction pathway5a, 5d was 
followed, the isoindolinediol intermediate 36 formed from 35 could undergo either a loss of 
HDO leading to 37, and subsequently to 18a, or a loss of water leading to 38, and 
subsequently to the deuterated 19a’ (Scheme 5). In this case, only one of the two predicted 
products is deuterated. Analogous reasoning can be applied to the reaction of mono-
deuterated 39 (Scheme 6) and would predict the formation of one mono-deuterated isomer 
18a’ along with the non-deuterated 19a. 
 
<<Single column>> 
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Scheme 5: The predicted products formed from mono-deuterated 35 considering the likely 
isoindolinediol intermediate 36. Loss of HDO or water from 36 would lead to 37 or 38 and 
then to 18a and 19a’ respectively via tautomerisation. An alternative mechanism proposed in 
the literature5a,5c,5e,5f involving a a [1,3]-deuteride or a [1,3]-hydride shift was ruled out based 
on stereoelectronic considerations in response to a comment during the review of this paper 
(see reference 5(f)). 
 
Mono-deuterated 35 and 39 were successfully synthesised with the key deuterium 
incorporation step being achieved using sodium borodeuteride reduction of lactones 40 and 
41 (Figure 4a, SI1 part II.1.1. and part VI.2.)12 followed by Swern oxidation13 of 42 and 43 
respectively. 1H NMR spectra of 35 and 39 confirmed the presence of a monodeuterated 
aldehyde (Figure 4b). However, a signal consistent with potential traces of non-deuterated 
17a was observed in the 13C NMR spectrum of 39 (see SI2 for spectrum). Analysis of the 
condensation of 35 and 39 with alanine (16) at reflux was carried out by 13C NMR 
spectroscopy (Figure 4c). The spectra associated with both purified reaction mixtures differed 
from that of pure 18a and 19a in the signals that corresponded to the CH2 carbon only (red 
circle, Figure 4c). The 13C NMR analysis of the reaction of 35 (spectrum ii) showed a major 
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isomer with a singlet corresponding to the CH2 signal of 18a (c.f. spectrum i and ii). The 
observed triplet (blue bars, spectrum ii) suggested that the minor isomer was monodeuterated 
and thus corresponded to 19a’. Similarly, 13C NMR analysis of the reaction of 39 (spectrum 
iii) showed the presence of the undeuterated minor isomer 19a (singlet, c.f. spectrum iv with 
iii) and the monodeuterated major isomer 18a’ (triplet, blue bars, spectrum iii) with a small 
additional signal (labelled * in spectrum iii) assigned to the formation of trace amounts of 
undeuterated 18a (c.f. spectrum iii with i). Therefore, in both reactions, only one 
monodeuterated product was formed consistent with the reaction occurring as shown in 
Scheme 5. Further evidence to support this comes from work previously published by Pan et 
al.5a The presence of trace amounts of undeuterated 18a when using substrate 39 could 
potentially be explained by the initial contamination of substrate 39 with traces of 
undeuterated substrate 17a or by the reversibility of the final tautomerisation step. 
Interestingly, the regioisomeric ratios obtained with substrates 35 and 39 were slightly 
affected by the presence of a deuterium atom suggesting a kinetic isotope effect (SI1 part 
VI.3.). 
 
3. Conclusions 
Although unstable and challenging to obtain, eleven monosubstituted o-phthaldialdehydes 
were successfully synthesised. The result of their condensation reaction with alanine (16) led 
to the design of a disubstituted analogue 27 that reacted with 16 in a highly regioselective 
manner (rr of 88:12 on 30 mg scale). A gram-scale reaction using this substrate 27 followed 
by esterification led to the isolation of pure isoindolinone regioisomers in high yield and 
selectivity (rr of 84:16). Performing this condensation at room temperature provided an 
excellent regioisomeric ratio of 97:3. 
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<< single column>> 
 
Figure 4: a) Synthesis of monodeuterated substrates 35 and 39. Reagents and conditions: (a) 
NaBD4, ZnCl2, N,N-dimethylaniline, anhyd. THF, reflux, 20 h, 62% for 42, 49% for 43; (b) 
(COCl)2, anhyd. DCM, anhyd. DMSO, Et3N, rt, 15‒17 h, 67% for 35, 86% for 39; b) 
Aldehyde region of the 1H NMR spectra of 17a, 35 and 39. Only one aldehyde signal is 
present in the 1H NMR spectra of 35 and 39 (red lines) compared to the 1H NMR spectrum of 
17a supporting the formation of monodeuterated substrates; C) CH2 region of the 13C NMR 
spectrum of: i) 18a; ii) the purified mixture of isoindolinones obtained from the condensation 
of 35 with alanine (16); iii) the purified mixture of isoindolinones obtained from the 
condensation of 39 with alanine (16); iv) 19a. The condensation reaction of 35 led to a major 
isomer with a singlet corresponding to 18a and a minor isomer with a triplet (blue bars, 
spectrum ii) corresponding to monodeuterated 19a’. Similarly, the condensation reaction of 
39 led to a minor isomer with a singlet corresponding to 19a and a major isomer with a triplet 
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(blue bars, spectrum iii) corresponding to monodeuterated 18a’. *13C NMR signal consistent 
with traces of undeuterated 18a. 
 
In addition, the structure of the major regioisomers of the condensation reactions of 4-
monosubstituted substrates supported the view that this reaction most likely occurs through 
an isoindolinediol intermediate (44 from 8,Scheme 6). Two routes have been proposed in the 
literature to form the final isoindolinone product from such an intermediate.5a,5c,5d The 
synthesis and condensation reaction of two additional monodeuterated substrates supported a 
mechanism that most likely occurs via loss of water from 44 and a subsequent 
tautomerisation of 45 to give the more thermodynamically stable 4 (Scheme 6). 
 
 
<< single column>> 
 
 
Scheme 6: Proposed condensation reaction mechanism based on this study. Addition of 
amine RNH2 to o-phthaldialdehyde (8) leads to isoindolinediol intermediate 44. A water loss 
followed by tautomerisation of 45 would then provide the desired product 4. 
 
4. Experimental section 
General methods: All solvents and chemicals were purchased from Sigma Aldrich, Alfa 
Aeser, Acros Organics, Fluorochem, Apollo Scientific or Fisher Scientific and used without 
further purification. All air or moisture sensitive reactions were carried out in flame or oven-
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dried glassware under a positive pressure of nitrogen. Thin layer chromatography (TLC) 
analysis was performed using glass plates coated with silica gel (with fluorescent indicator 
UV254). Developed plates were air dried and analysed under a UV lamp (254/365 nm). Flash 
chromatography was performed using silica gel (40-62 µm, Fluorochem). Melting points 
were measured using Electrothermal 9100 capillary melting point apparatus. Values are 
quoted to the nearest 1 °C and are uncorrected. Fourier Transform infra-red spectra (FT IR) 
were acquired on a Shimadzu IR Affinity-1 Fourier transform IR spectrophotometer using 
thin films, a Pike MIRacle ATR accessory and Shimadzu IR solution v1.50 for analysis. 
Absorption maxima (νmax) are reported in wavenumbers (cm-1). Broad signals were assigned 
with as br. Nuclear magnetic resonance (NMR) spectra were acquired at room temperature on 
a Brüker Advance 500 (1H, 500 MHz; 13C, 125 MHz), a Brüker Advance 400 (1H, 400 MHz; 
13C, 100 MHz) or a Brüker Advance 300 (1H, 300 MHz; 13C, 75 MHz) instruments. 
Deuterium solvents were used as lock for all NMR spectra and 1H NMR shifts were 
internally referenced to the solvent. Chemical shifts are expressed as δ in units of ppm. 13C 
NMR spectra were recorded using the PENDANT sequence mode. Data processing was 
carried out using MestReNova 9.0 NMR program (Brüker UK Ltd). Signals for protons and 
carbons were assigned, as far as possible, by using the following two-dimensional NMR 
spectroscopy techniques: [1H, 1H] COSY (COrrelation SpectroscopY), [1H, 13C] HSQC 
(Heteronuclear Single Quantum Coherence) and [1H, 13C] HMBC (Heteronuclear Multiple 
Bond Connectivity). For 1H NMR, the multiplicity is indicated by the following 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br. = broad. The 
CH2 proton NMR signals corresponding to the isoindolinone ring appeared as a singlet, a 
multiplet or as two apparent doublets with a roofing effect which are referred to as doublets 
hereafter. All 13C NMR signals were singlets (except for compounds containing F) and 
correspond to one carbon unless otherwise stated. Mass spectrometric analysis (electrospray 
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mode, ES, or atmospheric solids analysis probe mode, ASAP) was carried out on a high 
performance orthogonal acceleration reflecting TOF (Time Of Flight) mass spectrometer 
operating in positive and negative mode, coupled to a Waters 2975 HPLC.  
General procedures 
General procedure A: Swern oxidation 
To a solution of (COCl)2 (2.6 equiv.) in anhydrous DCM (1.4 mL per mmol of diol) was 
added dropwise a solution of anhydrous DMSO (5.2 equiv.) in anhydrous DCM (2.2 mL per 
mmol of diol) at ‒78 °C and under a nitrogen atmosphere. After 10 mins. stirring at ‒78 °C, a 
solution of diol (1.0 equiv.) in anhydrous DCM (2.2 mL per mmol of diol) was added at this 
temperature. The reaction mixture was stirred at ‒78 °C for 1 h under a nitrogen atmosphere 
before Et3N (1.4 mL per mmol of diol) was added dropwise. The reaction mixture was 
warmed to rt and stirred for 2‒18 h under a nitrogen atmosphere. The reaction was then 
quenched by addition of H2O. The organics were extracted with DCM, combined, washed 
with water, washed with brine, dried over MgSO4 and concentrated in vacuo to afford the 
desired o-phthaldialdehyde. 
General procedure B: Condensation reaction 
Alanine (16, 1.2 equiv.) was added to a solution of unsymmetrical o-phthaldialdehyde (1.0 
equiv.) in anhydrous MeCN (3.8 mL per mmol of o-phthaldialdehyde). The reaction mixture 
was heated at reflux for 4 h under a nitrogen atmosphere. The solution was then cooled to rt 
before being concentrated in vacuo to afford the crude mixture of regioisomers. 
Quantitative 1H NMR analysis (SI1 part III.1) was carried out on this crude reaction mixture 
to obtain the average percentage of the major regioisomer with its 95% confidence interval 
(SI1 part III.3) and subsequently the regioisomeric ratio (rr, Table 1). The NMR spectrum 
was processed using MestReNova 9.0 as follows: (i) the baseline was corrected using the 
Whittaker smoother; (ii) the peaks were selected by manual threshold following a Global 
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Spectral Deconvolution (GSD) with a refinement level of 4 (20 fitting cycles). When the 
peaks were too overlapped to allow an accurate deconvolution, they were not used in the 
subsequent steps; (iii) the integral for each peak was calculated using the peaks method and 
applying an automatic integration; (iv) when the integrals of two distinguishable signals were 
overlapping, manual removal of one signal allowed the integral of the remaining signal to be 
obtained. For each signal, the contribution was calculated relative to one proton (CH2 
integrals were divided by 2, CH3 integrals were divided by 3 and the integration of an 
aromatic signal corresponding to two protons belonging to the same regioisomer was divided 
by 2). Using as many signals as possible, an average regioisomeric ratio with its standard 
deviation was then calculated using Excel Microsoft Office software. The desired 95% 
confidence interval was then calculated using the following formula: 
=CONFIDENCE.NORM(0,05;standard deviation; number of ratio calculated). The crude 
product was then purified by column chromatography (0‒10% MeOH in DCM then 0‒10% 
MeOH in DCM with 1% CH3COOH) to afford the pure regioisomeric mixture and to enable 
calculation of the yield. 
 
General procedure C: Reduction of lactone using NaBD4 
To a solution of lactone (1 equiv.) in anhydrous THF (1 mL per mmol of lactone) under a 
nitrogen atmosphere were added cautiously NaBD4 (2 equiv.), ZnCl2 (1 equiv.) and N,N-
dimethylaniline (1 equiv.). The reaction was refluxed for 20 h under a nitrogen atmosphere 
before being cooled to 0 °C and quenched cautiously with an aqueous solution of NH4Cl 
(10%). The grey solid formed was filtered off and washed with DCM. The filtrate was 
extracted with DCM. The organics were combined, washed with water, washed with brine, 
dried over MgSO4 and concentrated in vacuo to afford the crude product. Purification by 
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column chromatography (0‒100% EtOAc in petroleum ether) afforded the desired deuterated 
diol. 
Compounds synthesised 
3-Methoxyphthalaldehyde (17a)13  
17a was synthesised according to general procedure A using (3-methoxy-1,2-
phenylene)dimethanol (23a, 1.0 equiv., 500 mg, 2.97 mmol), (COCl)2 (2.6 equiv., 0.66 mL, 
7.73 mmol), DMSO (5.2 equiv., 1.10 mL, 15.40 mmol). Additional DMSO (1 mL) was 
required to help 23a solubilisation. The reaction was stirred at rt for 17 h. Pure 17a was 
obtained after recrystallisation from EtOAc as a yellow gum (249 mg, 1.52 mmol, 51%).  
1H NMR (400 MHz, CDCl3) δH 10.62 (s, 1H, H1’’), 10.41 (s, 1H, H1’), 7.63 (t, J = 8.0 Hz, 
1H, H5), 7.42 (d, J = 8.0 Hz, 1H, H6), 7.23 (d, J = 8.0 Hz, 1H, H4), 3.97 (s, 3H, OCH3). 
Spectral data in accordance with those reported in the literature.13  
2-(4-Methoxy-1-oxoisoindolin-2-yl)propanoic acid (18a) with 2-(7-methoxy-1-
oxoisoindolin-2-yl)propanoic acid (19a) 
A mixture of 18a and 19a was synthesised according to general procedure B using 4-
methoxyphthalaldehyde (17a, 1.0 equiv., 30 mg, 0.18 mmol) and alanine (16, 1.2 equiv., 19 
mg, 0.22 mmol). A pure regioisomeric mixture of 18a and 19a was obtained as a light yellow 
solid (32 mg, 0.14 mmol, 78%). Each regioisomer was also synthesised in pure form via a 
different method (SI1 part III.2) and their characterisation is reported here. 
18a: Mp: 205‒208 °C; IR νmax cm-1 (thin film) 2943 (O-H stretch), 1721 (C=O stretch), 1628 
(C=O stretch), 1605 (C=C stretch), 1497 (C=C stretch), 1275 (C-O stretch), 1061, 806; 1H 
NMR (400 MHz, CD3OD) δH 7.48 (t, J = 8.0 Hz, 1H, H6), 7.36 (d, J = 7.8 Hz, 1H, H7), 7.19 
(d, J = 8.0 Hz, 1H, H5), 4.99 (q, J = 7.5 Hz, 1H, CH), 4.53 (d, J = 17.5 Hz, 1H, H3), 4.47 (d, 
J = 17.5 Hz, 1H, H3), 3.93 (s, 3H, OCH3), 1.62 (d, J = 7.5 Hz, 3H, CH3); 13C NMR (100 
MHz, CD3OD) δc 174.7 (COOH), 171.0 (C1), 156.2 (C4), 134.5 (C7a), 131.4 (C3a), 131.1 
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(C6), 116.2 (C7), 114.6 (C5), 56.1 (OCH3), 51.0 (CH), 46.3 (C3), 15.9 (CH3); HRMS (ES+) 
m/z calculated for C12H14NO4 [M+H]+: 236.0917; found: 236.0918. See SI1 part IX for 
experimental procedure and SI2 for 1H and 13C NMR spectra. 
19a: Mp: 218‒220 °C; IR νmax cm-1 (thin film) 2934 (O-H stretch), 1728 (C=O stretch), 1636 
(C=O stretch), 1612 (C=C stretch), 1489 (C-H bend), 1456 (C-H bend), 1279 (C-N stretch), 
1204 (C-O stretch), 1180 (C-O stretch), 1084, 773; 1H NMR (500 MHz, CD3OD) δH 7.55 (t, 
J = 8.0 Hz, 1H, H5), 7.11 (d, J = 8.0 Hz, 1H, H4), 7.02 (d, J = 8.0 Hz, 1H, H6), 4.96 (q, J = 
7.5 Hz, 1H, CH), 4.54 (d, J = 17.5 Hz, 1H, H3), 4.47 (d, J = 17.5 Hz, 1H, H3), 3.91 (s, 3H, 
OCH3), 1.59 (d, J = 7.5 Hz, 3H, CH3); 13C NMR (125 MHz, CD3OD) δc 174.9 (COOH), 
170.0 (C1), 158.8 (C7), 146.3 (C3a), 135.0 (C5), 120.1 (C7a), 116.2 (C4), 111.2 (C6), 56.0 
(OCH3), 50.7 (CH), 48.0 (C3), 15.8 (CH3); HRMS (ES+) m/z calculated for C12H14NO4 
[M+H]+: 236.0917; found: 236.0917. See SI1 part IX for experimental procedure and SI2 for 
1H and 13C NMR spectra. 
2-(4-Methyl-1-oxoisoindolin-2-yl)propanoic acid (18b) with 2-(7-methyl-1-oxoisoindolin-
2-yl)propanoic acid (19b) via 3-methylphtalaldehyde (17b) 
17b was synthesised according to general procedure A using (3-methyl-1,2-
phenylene)dimethanol (23b, 1.0 equiv., 100 mg, 0.66 mmol), (COCl)2 (2.6 equiv., 0.15 mL, 
1.77 mmol) and DMSO (5.2 equiv., 0.24 mL, 3.43 mmol). The reaction was stirred at rt for 2 
h. Crude 17b was obtained contaminated with a small amount of impurities (73 mg, 0.49 
mmol, 75% assuming pure 17b) Characterisation was performed on this slightly impure 
mixture with the 1H and 13C NMR signals reported for 17b only.  
IR νMax cm-1 (Thin Film) 2922 (C-H stretch), 1690 (C=O stretch), 1481 (C-H bend), 1358, 
1260, 1086, 1067, 1038; 907, 866, 775; 1H NMR (500 MHz, CDCl3) δH 10.59 (s, 1H, H1’’), 
10.21 (s, 1H, H1’), 7.72 (d, J = 7.5 Hz, 1H, H6), 7.57 (t, J = 7.5 Hz, 1H, H5), 7.49 (d, J = 7.5 
Hz, 1H, H4), 2.59 (s, 3H, CH3); 13C NMR (125 MHz, CDCl3) δC 193.7 (C1’’), 192.8 (C1’), 
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140.0 (C3), 137.3 (C1), 136.7 (C4), 135.9 (C2), 132.4 (C5), 129.3 (C6), 19.5 (CH3); HRMS 
(ES+) m/z calculated for C9H9O2 [M+H]+: 149.0597; found: 149.0595. See SI2 for 1H and 13C 
NMR spectra. 
A portion of this impure mixture (1.0 equiv., 30 mg, 0.20 mmol assuming pure 17b) was 
treated according to general procedure B using alanine (16, 1.2 equiv., 22 mg, 0.24 mmol). A 
pure regioisomeric mixture of 18b and 19b was obtained as a light yellow solid (29 mg, 0.13 
mmol, 49% extrapolated yield over 2 steps). The 1H and 13C NMR signals integration are 
given assuming a mixture of 18b:19b with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2916 (O-H stretch), 2361 (C-H stretch), 1734 (C=O stretch), 1636 
(C=O stretch), 1609 (C=C stretch), 1456 (O-H bend), 1211 (C-O stretch), 1175 (C-O stretch); 
1H NMR (400 MHz, CD3OD) δH 7.60 (dd, J = 6.0, 2.9 Hz, 1H, H7 in 18b), 7.45 (t, J = 7.5 
Hz, 1H, H5 in 19b), 7.42-7.38 (m, 2H, H5 and H6 in 18b), 7.36 (d, J = 7.5 Hz, 1H, H4 in 
19b), 7.22 (d, J = 7.5 Hz, 1H, H6 in 19b), 5.02 (q, J = 7.5 Hz, 1H, CH in 18b), 4.98 (q, J = 
7.5 Hz, 1H, CH in 19b), 4.58-4.45 (m, 4H, H3 in 18b, H3 in 19b), 2.65 (s, 3H, H1’ in 19b), 
2.39 (s, 3H, H1’ in 18b), 1.64 (d, J = 7.5 Hz, 3H, CH3 in 18b), 1.60 (d, J = 7.5 Hz, 3H, CH3 
in 19b); 13C NMR (175 MHz, CD3OD) δC 175.0 (COOH in 19b), 174.8 (COOH in 18b), 
171.6 (C1 in 19b), 171.4 (C1 in 18b), 144.2 (C3a in 19b), 142.5 (C4 in 18b), 138.4 (C7 in 
19b), 134.4 (C3a or C7a in 18b), 133.9 (C5 in 18b), 132.7 (2C, C5 in 19b, C3a or C7a in 
18b), 130.9 (C6 in 19b), 130.1 (C7a in 19b), 129.4 (C6 in 18b), 121.73 (C4 in 19b or C7 in 
18b), 121.67 (C4 in 19b or C7 in 18b), 51.0 (CH in 18b), 50.7 (CH in 19b), 47.8 (C3 in 19b), 
47.7 (C3 in 18b), 17.52 (C1’ in 18b or 19b), 17.45 (C1’ in 18b or 19b), 16.0 (CH3 in 18b), 
15.9 (CH3 in 19b); HRMS (ES-) m/z calculated for C12H12NO3 [M-H]-: 218.0823; found: 
218.0823. See SI2 for 1H and 13C NMR spectra. 
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2-(1-Oxo-4-(trifluoromethyl)isoindolin-2-yl)propanoic acid (18c) with 2-(1-oxo-7-
(trifluoromethyl)isoindolin-2-yl)propanoic acid (19c) via 3-
(trifluoromethyl)phthalaldehyde (17c) 
To a solution of 2-(1,3-dioxolan-2-yl)-6-(trifluoromethyl)benzaldehyde (24c, 1 equiv., 100 
mg, 0.41 mmol) in DCM (5 mL) was added an aqueous solution of HCl (2 M, 5 mL). The 
reaction was stirred at rt for 15 h. Water was added and the organics were extracted with 
DCM, combined, washed with brine, dried over MgSO4 and concentrated in vacuo. 17c was 
obtained impure (24 mg). The considerable amount of impurities prevented any 
characterisation. Instead, this impure mixture (1.0 equiv., 24 mg, 0.12 mmol assuming pure 
17c) was directly treated according to general procedure B using alanine (16, 1.2 equiv., 13 
mg, 0.14 mmol). A pure regioisomeric mixture of 18c and 19c was obtained as a light brown 
oil (12 mg, 0.04 mmol, 11% yield over 2 steps). The small amount of product available did 
not allow the identification of the 13C NMR signals corresponding to C4, CF3 in 18c and C7, 
CF3 in 19c and allowed the visibility of grease impurities in the 1H and 13C NMR spectra. 
Additionally, the 13C NMR signals corresponding to COOH in 18c and in 19c were 
extrapolated from the HMBC spectrum (SI1 part VII). The 1H and 13C NMR signal 
integration are given assuming a mixture of 18c:19c with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2922 (O-H stretch), 2359 (C-H stretch), 1684 (br. C=O stretch), 
1558 (C=C stretch), 1456 (O-H bend), 1325 (C-F stretch), 1117 (C-F stretch);  1H NMR (400 
MHz, CD3OD) δH 8.04 (d, J = 7.5 Hz, 1H, H7 in 18c), 7.93 (d, J = 7.5 Hz, 1H, H5 in 18c), 
7.86 (d, J = 7.5 Hz, 1H, H4 in 19c), 7.82 (d, J = 7.5 Hz, 1H, H6 in 19c), 7.78-7.72 (m, 2H, 
H5 in 19c, H6 in 18c), 5.03-4.97 (m, 2H, CH in 18c, CH in 19c), 4.83 (d, J = 18.0 Hz, 1H, 
H3 in 18c), 4.74 (d, J = 18.0 Hz, 1H, H3 in 18c), 4.70 (d, J = 17.5 Hz, 1H, H3 in 19c), 4.62 
(d, J = 17.5 Hz, 1H, H3 in 19c), 1.64 (d, J = 7.5 Hz, 3H, CH3 in 18c), 1.63 (d, J = 8.0 Hz, 3H, 
CH3 in 19c); 13C NMR (175 MHz, CD3OD) δC 174.0 (2C, COOH in 18c, COOH in 19c, 
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extrapolated from the HMBC spectrum, SI1 part VII), 169.2 (C1 in 18c), 167.4 (C1 in 19c), 
146.4 (C3a in 19c), 140.7 (C3a in 18c), 135.1 (C7a in 18c), 132.9 (C5 in 19c), 130.3 (C6 in 
18c), 129.9-129.8 (m, C5 in 18c), 128.5 (C4 in 19c), 128.3 (C7 in 18c), 126.8 (C7a in 19c), 
126.6-126.5 (m, C6 in 19c), 51.7 (CH in 18c or 19c), 51.5 (CH in 18c or 19c), 48.2 (C3 in 
19c), 47.9 (C3 in 18c), 16.03 (CH3 in 18c or 19c), 16.00 (CH3 in 18c or 19c); HRMS (ES-) 
m/z calculated for C12H9NO3F3 [M-H]-: 272.0540; found:272.0540. See SI2 for 1H and 13C 
NMR spectra. 
2-(4-Chloro-1-oxoisoindolin-2-yl)propanoic acid (18d) with 2-(7-chloro-1-oxoisoindolin-
2-yl)propanoic acid (19d) via 3-chlorophtalaldehyde (17d) 
17d was synthesised according to general procedure A using (3-chloro-1,2-
phenylene)dimethanol (23d, 1.0 equiv., 100 mg, 0.58 mmol), (COCl)2 (2.6 equiv., 0.13 mL, 
1.51 mmol) and DMSO (5.2 equiv., 0.21 mL, 3.02 mmol). The reaction was stirred at rt for 2 
h. Crude 17d was obtained with small impurities (51 mg, 0.30 mmol, 52% assuming pure 
17d) Characterisation was performed on this slightly impure mixture with the 1H and 13C 
NMR signals reported for 17d only. 
IR νMax cm-1 (Thin Film) 2924 (C-H stretch), 1695 (C=O stretch), 1591 (C=C stretch), 1460 
(C-H bend), 1354, 1292, 1175, 1144, 1078, 910, 862, 773; 1H NMR (500 MHz, CDCl3) δH 
10.64 (s, 1H, H1’’), 10.32 (s, 1H, H1’), 7.81 (d, J = 8.0 Hz, 1H, H6), 7.69 (d, J = 8.0 Hz, 1H, 
H4), 7.64 (t, J = 8.0 Hz, 1H, H5); 13C NMR (125 MHz, CDCl3) δC 191.3 (C1’ or C1’’), 191.2 
(C1’ or C1’’), 139.0 (C1), 137.5 (C3), 135.1 (C4), 134.3 (C5), 133.8 (C2), 127.7 (C6); 
HRMS (ES+) m/z calculated for C8H6O235Cl [M+H]+: 169.0051; found: 169.0046. See SI2 
for 1H and 13C NMR spectra. 
A portion of this impure mixture (1.0 equiv., 30 mg, 0.18 mmol assuming pure 17d) was 
treated according to general procedure B using alanine (16, 1.2 equiv., 19 mg, 0.21 mmol). A 
pure regioisomeric mixture of 18d and 19d was obtained as a yellow gum (27 mg, 0.11 
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mmol, 33% extrapolated yield over 2 steps). The 1H and 13C NMR signals integration are 
given assuming a mixture of 18d:19d with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2922 (O-H stretch), 2359 (C-H stretch), 1653 (br. C=O stretch), 
1558 (C=C stretch), 1456 (O-H bend), 1206 (C-O stretch), 1173 (C-O stretch); 1H NMR (400 
MHz, CD3OD) δH 7.74 (d, J = 7.5 Hz, 1H, H7 in 18d), 7.64 (d, J = 8.0 Hz, 1H, H5 in 18d), 
7.59-7.51 (m, 3H, H4 in 19d, H5 in 19d, H6 in 18d), 7.45 (d, J = 7.5 Hz, 1H, H6 in 19d), 
5.03-4.94 (m, 2H, CH in 18d, CH in 19d), 4.66 (d, J = 17.5 Hz, 1H, H3 in 18d), 4.63 (d, J = 
17.5 Hz, 1H, H3 in 19d), 4.57 (d, J = 17.5 Hz, 1H, H3 in 18d), 4.54 (d, J = 17.5 Hz, 1H, H3 
in 19d), 1.65 (d, J = 7.5 Hz, 3H, CH3 in 18d), 1.62 (d, J = 7.5 Hz, 3H, CH3 in 19d); 13C 
NMR (175 MHz, CD3OD) δC 175.4 (2C, COOH in 18d, COOH in 19d), 169.8 (C1 in 18d), 
168.4 (C1 in 19d), 146.5 (C3a in 19d), 141.6 (C3a in 18d), 135.4 (C7a in 18d), 134.0 (C5 in 
19d), 133.0 (C5 in 18d), 132.0 (C7 in 19d), 131.2 (C6 in 18d), 130.6 (C6 in 19d), 130.4 (C4 
in 18d), 129.1 (C7a in 19d), 123.1 (C4 in 19d), 123.0 (C7 in 18d), 51.6 (CH in 18d), 51.4 
(CH in 19d), 47.71 (C3 in 18d), 47.68 (C3 in 19d), 16.1 (CH3 in 18d), 15.9 (CH3 in 19d); 
HRMS (ES-) m/z calculated for C11H9NO335Cl [M-H]-: 238.0276; found: 238.0277. See SI2 
for 1H and 13C NMR spectra. 
3-Fluorophthalaldehyde (17e) 
To a solution of 2,2'-(3-fluoro-1,2-phenylene)bis(1,3-dioxolane) (25e, 1 equiv., 100 mg, 0.42 
mmol) in DCM (5 mL) was added an aqueous solution of HCl (2 M, 5 mL). The reaction was 
stirred at rt for 3 h. Water was added and the organics were extracted with DCM, combined, 
washed with brine, dried over MgSO4 and concentrated in vacuo. Pure 17e was obtained as a 
light orange gum (31 mg, 0.20 mmol, 49%). 
IR νMax cm-1 (Thin Film) 2928 (C-H stretch), 1694 (C=O stretch), 1603 (C=C stretch), 1479 
(C-H bend), 1248 (C-F stretch), 1094, 917, 783; 1H NMR (500 MHz, CDCl3) δH 10.56 (s, 
1H, H1’’), 10.49 (s, 1H, H1’), 7.75-7.69 (m, 2H, H5, H6), 7.45-7.41 (m, 1H, H4); 13C NMR 
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(125 MHz, CDCl3) δC 191.3 (d, J = 2.7 Hz, C1’), 188.6 (d, J = 8.3 Hz, C1’’), 164.4 (d, J = 
260.1 Hz, C3), 138.3 (C1), 135.8 (d, J = 9.5 Hz, C5), 125.0 (d, J = 3.3 Hz, C6), 124.3 (d, J = 
7.8 Hz, C2), 121.6 (d, J = 21.8 Hz, C4); HRMS (ASAP+) m/z calculated for C8H6O2F 
[M+H]: 153.0352; found: 153.0365. See SI2 for 1H and 13C NMR spectra. 
2-(4-Fluoro-1-oxoisoindolin-2-yl)propanoic acid (18e) with 2-(7-fluoro-1-oxoisoindolin-
2-yl)propanoic acid (19e) 
A mixture of 18e and 19e was synthesised according to general procedure B using 3-
fluorophthalaldehyde (17e, 1.0 equiv., 15 mg, 0.10 mmol) and alanine (16, 1.2 equiv., 11 mg, 
0.12 mmol). A pure regioisomeric mixture of 18e and 19e was obtained as a yellow solid (13 
mg, 0.06 mmol, 60%). The 1H and 13C NMR signals integration are given assuming a mixture 
of 18e:19e with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2918 (O-H stretch), 2359 (C-H stretch), 1749 (C=O stretch), 1653 
(C=O stretch), 1558 (C=C stretch), 1489 (C-H bend), 1456 (O-H bend), 1396, 1173 (C-F 
stretch); 1H NMR (700 MHz, CD3OD) δH 7.64-7.61 (m, 2H, H7 in 18e, H5 in 19e), 7.55 (td, 
J = 8.0, 4.5 Hz, 1H, H6 in 18e), 7.39 (d, J = 7.5 Hz, 1H, H4 in 19e), 7.36 (t, J = 8.0 Hz, 1H, 
H5 in 18e), 7.16 (t, J = 9.0 Hz, 1H, H6 in 19e), 5.00-4.94 (m, 2H, CH in 19e, CH in 18e), 
4.69 (d, J = 17.5 Hz, 1H, H3 in 18e), 4.65-4.63 (m, 2H, H3 in 19e, H3 in 18e), 4.58 (d, J = 
17.5 Hz, 1H, H3 in 19e), 1.63 (d, J = 7.5 Hz, 3H, CH3 in 18e), 1.61 (d, J = 7.5 Hz, 3H, CH3 in 
19e); 13C NMR (175 MHz, CD3OD) δC 175.1 (2C, COOH in 18e, COOH in 19e), 169.8 (C1 
in 18e), 167.8 (C1 in 19e), 160.1 (d, J = 257.8 Hz, C7 in 19e), 159.0 (d, J = 249.4 Hz, C4 in 
18e), 146.7 (d, J = 2.5 Hz, C3a in 19e), 136.3 (d, J = 4.8 Hz, C7a in 18e), 135.3 (d, J = 7.5 
Hz, C5 in 19e), 131.7 (d, J = 6.5 Hz, C6 in 18e), 129.5 (d, J = 18.6 Hz, C3a in 18e), 120.54 
(d, J = 4.1 Hz, C4 in 19e or C7 in 18e), 120.47 (d, J = 3.7 Hz, C4 in 19e or C7 in 18e), 120.3 
(d, J = 13.2 Hz, C7a in 19e) 119.6 (d, J = 19.7 Hz, C5 in 18e), 116.0 (d, J = 19.4 Hz, C6 in 
19e), 51.5 (CH in 18e), 51.1 (CH in 19e), 48.4 (C3 in 19e), 45.4 (C3 in 18e), 15.95 (CH3 in 
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18e or 19e), 15.92 (CH3 in 18e or 19e); HRMS (ES-) m/z calculated for C11H9NO3F [M-H]-: 
222.0572; found: 222.0572. See SI2 for 1H and 13C NMR spectra. 
4-Methoxyphthalaldehyde (20a)14  
2-(1,3-Dioxolan-2-yl)-4-methoxybenzaldehyde (24a, 1 equiv., 2.00 g, 9.6 mmol) was stirred 
in an aqueous solution of HCl (3 M, 330 mL) at rt for 16 h. The organics were extracted with 
Et2O, combined, washed with brine, dried over MgSO4 and concentrated in vacuo to afford 
pure 20a as an orange solid (1.35 g, 8.2 mmol, 86%).  
Mp: 78‒81 °C (lit. 75‒78 °C)14; 1H NMR (400 MHz, CDCl3) δH 10.66 (s, 1H, CHO), 10.33 
(s, 1H, CHO), 7.93 (d, J = 8.5 Hz, 1H, H6), 7.45 (d, J = 3.0 Hz, 1H, H3), 7.22 (dd, J = 8.5, 
3.0 Hz, 1H, H5), 3.95 (s, 3H, OCH3). Spectral data in accordance with those reported in the 
literature.14  
2-(6-Methoxy-1-oxoisoindolin-2-yl)propanoic acid (21a) with 2-(5-methoxy-1-
oxoisoindolin-2-yl)propanoic acid (22a) 
A mixture of 21a and 22a was synthesised according to general procedure B using 4-
methoxyphthalaldehyde (20a, 1.0 equiv., 30 mg, 0.18 mmol) and alanine (16, 1.2 equiv., 19 
mg, 0.22 mmol). A pure regioisomeric mixture of 21a and 22a was obtained as a light orange 
solid (38 mg, 0.16 mmol, 90%). Each regioisomer was synthesised in pure form via a 
different method (SI1 part III.2.) and their characterisation is reported here. 
21a: Mp: 194‒196 °C; IR νmax cm-1 (thin film) 3370 (O-H stretch), 1730 (C=O stretch), 1636 
(C=O stretch), 1493 (C=C stretch), 1456 (C-H bend), 1447 (C-H bend), 1196 (C-O stretch), 
1022, 770; 1H NMR (500 MHz, CD3OD) δH 7.48 (d, J = 8.5 Hz, 1H, H4), 7.29 (d, J = 2.5 
Hz, 1H, H7), 7.19 (dd, J = 8.5, 2.5 Hz, 1H, H5), 5.00 (q, J = 7.5 Hz, 1H, CH), 4.54 (d, J = 
17.0 Hz, 1H, H3), 4.48 (d, J = 17.0 Hz, 1H, H3), 3.86 (s, 3H, OCH3), 1.61 (d, J = 7.5 Hz, 3H, 
CH3); 13C NMR (125 MHz, CD3OD) δc 174.8 (COOH), 171.0 (C1), 161.6 (C6), 135.8 (C3a), 
134.3 (C7a), 125.2 (C4), 121.0 (C5), 107.4 (C7), 56.1 (OCH3), 51.2 (CH), 48.1 (C3), 15.9 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 33
(CH3); HRMS (ES+) m/z calculated for C12H14NO4 [M+H]+: 236.0917; found: 236.0921. See 
SI1 part IX for experimental procedure and SI2 for 1H and 13C NMR spectra. 
22a: Mp: 191‒193 °C; IR νmax cm-1 (thin film) 3229 (O-H stretch), 1717 (C=O stretch), 1628 
(C=O stretch), 1611 (C=C stretch), 1558 (C=C stretch), 1506 (C=C stretch), 1447 (C-H 
bend), 1435 (C-H bend), 1298 (C-N stretch), 1206 (C-O stretch), 1086, 1026, 845, 775; 1H 
NMR (500 MHz, CD3OD) δH 7.68 (d, J = 8.5 Hz, 1H, H7), 7.13 (d, J = 2.0 Hz, 1H, H4), 7.04 
(dd, J = 8.5, 2.2 Hz, 1H, H6), 4.98 (q, J = 7.5 Hz, 1H, CH), 4.57 (d, J = 17.0 Hz, 1H, H3), 
4.50 (d, J = 17.0 Hz, 1H, H3), 3.88 (s, 3H, OCH3), 1.60 (d, J = 7.5 Hz, 3H, CH3); 13C NMR 
(125 MHz, CD3OD) δc 174.8 (COOH), 171.0 (C1),164.9 (C5), 146.2 (C3a), 125.6 (C7), 
125.4 (C7a), 116.3 (C6), 108.8 (C4), 56.2 (OCH3), 50.9 (CH), 48.4 (C3), 15.9 (CH3); HRMS 
(ES+) m/z calculated for C12H14NO4 [M+H]+: 236.0917; found: 236.0921. See SI1 part IX for 
experimental procedure and SI2 for 1H and 13C NMR spectra. 
4-Fluorophthalaldehyde (20b)14  
20b was synthesised according to general procedure A using (4-fluoro-1,2-
phenylene)dimethanol (26b, 1.0 equiv., 200 mg, 1.28 mmol), (COCl)2 (2.6 equiv., 0.3 mL, 
3.33 mmol), DMSO (5.2 equiv., 0.5 mL, 6.66 mmol). The reaction was stirred at rt for 17 h. 
Pure 20b was obtained as a yellow gum (150 mg, 0.99 mmol, 77%).  
1H NMR (400 MHz, CDCl3) δH 10.60 (d, J = 2.0 Hz, 1H, CHO), 10.42 (s, 1H, CHO), 8.02 
(dd, J = 8.5, 5.2 Hz, 1H, H6), 7.67 (dd, J = 8.5, 2.5 Hz, 1H, H3), 7.45 (ddd, J = 8.5, 7.5, 2.5 
Hz, 1H, H5). Spectral data in accordance with those reported in the literature.14  
2-(6-Fluoro-1-oxoisoindolin-2-yl)propanoic acid (21b) with 2-(5-fluoro-1-oxoisoindolin-
2-yl)propanoic acid (22b) 
A mixture of 21b and 22b was synthesised according to general procedure B using 4-
fluorophthalaldehyde (20b, 1.0 equiv., 22 mg, 0.14 mmol) and alanine (16, 1.2 equiv., 15 mg, 
0.17 mmol). A pure regioisomeric mixture of 21b and 22b was obtained as an orange oil (30 
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mg, 0.13 mmol, 93%). The 1H and 13C NMR signals integration are given assuming a mixture 
of 21b:22b with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2924 (O-H stretch), 1732 (C=O stretch), 1647 (br. C=O stretch), 
1487 (C-H bend), 1456 (O-H bend), 1207 (C-F stretch), 1179 (C-O stretch), 772; 1H NMR 
(700 MHz, CD3OD) δH 7.79 (dd, J = 8.5, 4.9 Hz, 1H, H7 in 22b), 7.60 (dd, J = 8.5, 4.5 Hz, 
1H, H4 in 21b), 7.46 (d, J = 8.0 Hz, 1H, H7 in 21b), 7.38-7.34 (m, 2H, H4 in 22b, H5 in 
21b), 7.25 (t, J = 8.5 Hz, 1H, H6 in 22b), 5.01-4.96 (m, 2H, CH in 21b, CH in 22b), 4.65-
4.53 (m, 4H, H3 in 21b, H3 in 22b), 1.612 (d, J = 7.5 Hz, 3H, CH3 in 21b), 1.607 (d, J = 7.5 
Hz, 3H, CH3 in 22b); 13C NMR (175 MHz, CD3OD) δC 174.9 (COOH in 22b), 174.8 
(COOH in 21b), 169.9 (C1 in 21b or 22b), 169.8 (C1 in 21b or 22b), 166.8 (d, J = 250.1 Hz, 
C5 in 22b), 164.2 (d, J = 245.5 Hz, C6 in 21b), 146.5 (d, J = 10.6 Hz, C3a in 22b), 139.4 
(C3a in 21b), 135.1 (d, J = 8.6 Hz, C7a in 21b), 129.3 (C7a in 22b), 126.5 (d, J = 9.8 Hz, C7 
in 22b), 126.3 (d, J = 8.4 Hz, C4 in 21b), 120.5 (d, J = 23.9 Hz, C5 in 21b), 116.8 (d, J = 
23.9 Hz, C6 in 22b), 111.6 (d, J = 24.7 Hz, C4 in 22b), 110.6 (d, J = 23.8 Hz, C7 in 21b), 
51.3 (CH in 21b), 51.2 (CH in 22b), 48.3 (C3 in 22b), 48.2 (C3 in 21b), 15.9 (2C, CH3 in 
21b, CH3 in 22b); HRMS (ES-) m/z calculated for C11H9NO3F [M-H]-: 222.0572; found: 
222.0567. See SI2 for 1H and 13C NMR spectra. 
4-Bromophthalaldehyde (20c)15  
20c was synthesised according to general procedure A using (4-bromo-1,2-
phenylene)dimethanol (26c, 1.0 equiv., 100 mg, 0.46 mmol), (COCl)2 (2.6 equiv., 0.10 mL, 
1.20 mmol), DMSO (5.2 equiv., 0.17 mL, 2.40 mmol) and additional DMSO (0.15 mL) was 
required to help 26c solubilisation. The reaction was stirred at rt for 14 h. Pure 20c was 
obtained as a light yellow solid (86 mg, 0.41 mmol, 88%). 
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Mp: 95‒98 °C (lit. 97‒100 °C)16;  1H NMR (500 MHz, CDCl3) δH 10.51 (s, 1H, CHO), 10.45 
(s, 1H, CHO), 8.10 (d, J = 2.0 Hz, 1H, H3), 7.91 (dd, J = 8.0, 2.0 Hz, 1H, H5), 7.84 (d, J = 
8.0 Hz, 1H, H6). Spectral data in accordance with those reported in the literature.15  
2-(6-Bromo-1-oxoisoindolin-2-yl)propanoic acid (21c) with 2-(5-bromo-1-oxoisoindolin-
2-yl)propanoic acid (22c) 
A mixture of 21c and 22c was synthesised according to general procedure B using 4-
bromophthalaldehyde (20c, 1.0 equiv., 15 mg, 0.070 mmol) and alanine (16, 1.2 equiv., 8 mg, 
0.084 mmol). A pure regioisomeric mixture of 21c and 22c was obtained as a light orange oil 
(18 mg, 0.063 mmol, 90%). The 1H and 13C NMR signals integration are given assuming a 
mixture of 21c:22c with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2920 (O-H stretch), 2359 (C-H stretch), 1732 (C=O stretch), 1653 
(br. C=O stretch), 1456 (O-H bend), 1418 (C-H bend), 1204 (C-O stretch), 768; 1H NMR 
(700 MHz, CD3OD) δH 7.90 (s, 1H, H7 in 21c), 7.80 (s, 1H, H4 in 22c), 7.76 (d, J = 8.0 Hz, 
1H, H5 in 21c), 7.68-7.67 (m, 2H, H6 in 22c, H7 in 22c), 7.53 (d, J = 8.0 Hz, 1H, H4 in 21c), 
4.989 (q, J = 7.5 Hz, 1H, CH in 21c), 4.985 (q, J = 7.5 Hz, 1H, CH in 22c), 4.64-4.52 (m, 4H, 
H3 in 21c, H3 in 22c), 1.613 (d, J = 7.5 Hz, 3H, CH3 in 21c), 1.609 (d, J = 7.5 Hz, 3H, CH3 
in 22c); 13C NMR (175 MHz, CD3OD) δC 174.8 (2C, COOH in 21c, COOH in 22c), 169.9 
(C1 in 22c), 169.4 (C1 in 21c), 145.8 (C3a in 22c), 142.7 (C3a in 21c), 136.0 (C5 in 21c), 
135.3 (C7a in 21c), 132.6 (C6 in 22c), 132.2 (C7a in 22c), 127.8 (C4 in 22c), 127.6 (C5 in 
22c), 127.2 (C7 in 21c), 126.3 (C4 in 21c), 125.8 (C7 in 22c), 122.9 (C6 in 21c), 51.3 (CH in 
21c), 51.2 (CH in 22c), 48.4 (C3 in 21c), 48.2 (C3 in 22c), 16.0 (2C, CH3 in 21c, CH3 in 
22c); HRMS (ASAP+) m/z calculated for C11H11NO379Br [M+H]: 283.9922; found: 
283.9919. See SI2 for 1H and 13C NMR spectra. 
4-Methylphthalaldehyde (20d)17  
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20d was synthesised according to general procedure A using (4-methyl-1,2-
phenylene)dimethanol (26d, 1.0 equiv., 200 mg, 1.31 mmol), (COCl)2 (2.6 equiv., 0.29 mL, 
3.4 mmol), DMSO (5.2 equiv., 0.48 mL, 6.8 mmol). The reaction was stirred at rt for 17 h. 
Pure 20d was obtained as an orange gum (174 mg, 1.18 mmol, 90%). 
1H NMR (400 MHz, CDCl3) δH 10.53 (s, 1H, CHO) 10.44 (s, 1H, CHO), 7.86 (d, J = 8.0 Hz, 
1H, ArH), 7.75 (s, 1H, ArH), 7.56 (d, J = 8.0 Hz, 1H, ArH), 2.50 (s, 3H, CH3). Spectral data 
in accordance with those reported in the literature.17  
2-(6-Methyl-1-oxoisoindolin-2-yl)propanoic acid (21d) with 2-(5-methyl-1-oxoisoindolin-
2-yl)propanoic acid (22d) 
A mixture of 21d and 22d was synthesised according to general procedure B using 4-
methylphthalaldehyde (20d, 1.0 equiv., 26 mg, 0.18 mmol) and alanine (16, 1.2 equiv., 19 
mg, 0.22 mmol). A pure regioisomeric mixture of 21d and 22d was obtained as a yellow 
solid (29 mg, 0.13 mmol, 73%). The 1H and 13C NMR signals integration are given assuming 
a mixture of 21d:22d with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2914 (O-H stretch), 1734 (C=O stretch), 1638 (C=O stretch), 1456 
(O-H bend), 1198 (C-O stretch), 1173 (C-O stretch), 772; 1H NMR (700 MHz, CD3OD) δH 
7.64 (d, J = 8.0 Hz, 1H, H7 in 22d), 7.57 (s, 1H, H7 in 21d), 7.45 (d, J = 8.0 Hz, 1H, H4 in 
21d), 7.43 (d, J = 8.0 Hz, 1H, H5 in 21d), 7.38 (s, 1H, H4 in 22d), 7.31 (d, J = 8.0 Hz, 1H, 
H6 in 22d), 5.00-4.96 (m, 2H, CH in 22d, CH in 21d), 4.57 (d, J = 17.0 Hz, 2H, H3 in 21d, 
H3 in 22d), 4.48 (d, J = 17.0 Hz, 2H, H3 in 21d, H3 in 22d), 2.45 (s, 3H, H1’ in 22d), 2.43 
(s, 3H, H1’ in 21d), 1.59 (d, J = 7.5 Hz, 6H, CH3 in 21d, CH3 in 22d); 13C NMR (175 MHz, 
CD3OD) δC 175.4 (2C, COOH in 21d, COOH in 22d), 171.1 (2C, C1 in 21d, C1 in 22d), 
144.2 (C3a or C5 in 22d), 144.1 (C3a or C5 in 22d), 141.0 (C3a in 21d), 139.4 (C6 in 21d), 
134.1 (C5 in 21d), 133.2 (C7a in 21d), 130.5 (C7a in 22d), 130.1 (C6 in 22d), 124.7 (C4 in 
22d), 124.3 (C7 in 21d), 124.03 (C7 in 22d or C4 in 21d), 124.02 (C7 in 22d or C4 in 21d), 
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51.24 (CH in 21d), 51.17 (CH in 22d), 48.32 (C3 in 22d), 48.29 (C3 in 21d), 21.9 (C1’ in 
22d), 21.3 (C1’ in 21d), 16.1 (2C, CH3 in 21d, CH3 in 22d); HRMS (ASAP+) m/z calculated 
for C12H14NO3 [M+H]: 220.0974; found: 220.0973. See SI2 for 1H and 13C NMR spectra. 
2-(6-Trifluoromethyl-1-oxoisoindolin-2-yl)propanoic acid (21e) with 2-(5-
trifluoromethyl-1-oxoisoindolin-2-yl)propanoic acid (22e) via 4-
(trifluoromethyl)phtalaldehyde (20e) 
20e was synthesised according to general procedure A using (4-(trifluoromethyl)-1,2-
phenylene)dimethanol (26e, 1.0 equiv., 100 mg, 0.49 mmol), (COCl)2 (2.6 equiv., 0.11 mL, 
1.27 mmol), DMSO (5.2 equiv., 0.18 mL, 2.55 mmol). The reaction was stirred at rt for 15 h. 
Crude 20e was obtained with small amount of impurities (74 mg, 0.37 mmol, 75% assuming 
pure 20e). Characterisation was performed on this slightly impure mixture with the 1H and 
13C NMR signals reported for 20e only. The small intensity of the C4 and CF3 carbon signals 
on the 13C NMR spectrum revealed doublets instead of the expected quartets. 
IR νMax cm-1 (Thin Film) 2932 (C-H stretch), 1697 (C=O stretch), 1327 (C-F stretch), 1165, 
1121 (C-F stretch), 1057, 889, 831; 1H NMR (500 MHz, CDCl3) δH 10.58 (s, 1H, H1’), 10.55 
(s, 1H, H1’’), 8.23 (s, 1H, H3), 8.11 (d, J = 8.0 Hz, 1H, H6), 8.03 (d, J = 8.0 Hz, 1H, H5); 
13C NMR (125 MHz, CDCl3) δC 191.3 (C1’), 190.8 (C1’’), 138.8 (C1), 136.9 (C2), 135.5 (d, 
J = 33.8 Hz, C4), 131.7 (C6), 130.5 (q, J = 3.4 Hz, C5), 128.2 (q, J = 3.4 Hz, C3), 123.0 (d, J 
= 273.2 Hz, CF3); HRMS (ES-) m/z calculated for C9H5O2F3 [M]-: 202.0247; found: 
202.0247. See SI2 for 1H and 13C NMR spectra. 
A portion of this impure mixture (1.0 equiv., 30 mg, 0.15 mmol assuming pure 20e) was 
treated according to general procedure B using alanine (16, 1.2 equiv., 16 mg, 0.18 mmol). A 
pure regioisomeric mixture of 21e and 22e was obtained as an orange oil (30 mg, 0.11 mmol, 
55% extrapolated yield over 2 steps). The 1H and 13C NMR signals integration are given 
assuming a mixture of 21e:22e with a ratio of 1:1 for clarity. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 38
IR νMax cm-1 (Thin Film) 2924 (O-H stretch), 2359 (C-H stretch), 1717 (C=O stretch), 1653 
(br. C=O stretch), 1456 (O-H bend), 1325 (C-F stretch), 1161 (C-O stretch), 1117 (C-F 
stretch), 1057 (C-O stretch); 1H NMR (400 MHz, CD3OD) δH 8.05 (s, 1H, H7 in 21e), 7.96-
7.91 (m, 3H, H4 in 22e, H7 in 22e, H5 in 21e), 7.83-7.79 (m, 2H, H6 in 22e, H4 in 21e), 5.01 
(q, J = 7.5 Hz, 2H, CH in 21e, CH in 22e), 4.75 (d, J = 18.0 Hz, 1H, H3 in 21e), 4.73 (d, J = 
18.0 Hz, 1H, H3 in 22e), 4.66 (d, J = 18.0 Hz, 1H, H3 in 21e), 4.65 (d, J = 18.0 Hz, 1H, H3 
in 22e), 1.63 (d, J = 7.5 Hz, 6H, CH3 in 21e, CH3 in 22e); 13C NMR (175 MHz, CD3OD) δC 
174.5 (2C, COOH in 21e, COOH in 22e), 169.4 (2C, C1 in 21e, C1 in 22e), 147.6 (C3a in 
21e), 144.4 (C3a in 22e), 136.6 (C7a in 22e), 134.6 (q, J = 32.2 Hz, C5 in 22e), 134.0 (C7a in 
21e), 131.7 (q, J = 32.7 Hz, C6 in 21e), 129.8 (q, J = 4.0 Hz, C5 in 21e), 126.3 (q, J = 3.6 Hz, 
C6 in 22e), 125.6 (C4 in 21e), 125.38 (q, J = 271.5 Hz, CF3 in 21e or 22e), 125.37 (q, J = 
272.0 Hz, CF3 in 21e or 22e), 125.1 (C7 in 22e), 121.8 (q, J = 4.2 Hz, C4 in 22e), 121.2 (q, J 
= 4.2 Hz, C7 in 21e), 51.24 (CH in 21e or 22e), 51.20 (CH in 21e or 22e), 48.7 (2C, C3 in 
21e, C3 in 22e), 15.9 (2C, CH3 in 21e, CH3 in 22e); HRMS (ES-) m/z calculated for 
C12H9NO3F3 [M-H]-: 272.0540; found: 272.0540. See SI2 for 1H and 13C NMR spectra. 
2-(6-Nitro-1-oxoisoindolin-2-yl)propanoic acid (21f) with 2-(5-nitro-1-oxoisoindolin-2-
yl)propanoic acid (22f) via 4-nitrophtalaldehyde (20f) 
20f was synthesised according to general procedure A using (4-nitro-1,2-
phenylene)dimethanol (26f, 1.0 equiv., 100 mg, 0.55 mmol), (COCl)2 (2.6 equiv., 0.12 mL, 
1.43 mmol) and DMSO (5.2 equiv., 0.20 mL, 2.84 mmol). The reaction was stirred at rt for 
18 h. Crude 20f was obtained impure (110 mg, 0.61 mmol, >100% due to impurities). The 
considerable amount of impurities prevented any characterisation. Instead, a portion of this 
impure mixture (1.0 equiv., 30 mg, 0.17 mmol assuming pure 20f) was directly treated 
according to general procedure B using alanine (16, 1.2 equiv., 18 mg, 0.20 mmol). A pure 
regioisomeric mixture of 21f and 22f was obtained as an orange oil (13 mg, 0.05 mmol, 35% 
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extrapolated yield over 2 steps). The 1H and 13C NMR signal integration are given assuming a 
mixture of 21f:22f with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2922 (O-H stretch), 2357 (C-H stretch), 1732 (C=O stretch), 1651 
(br. C=O stretch), 1526 (N-O stretch), 1449 (O-H bend), 1341 (N-O stretch), 1196 (C-O 
stretch), 816; 1H NMR (400 MHz, CD3OD) δH 8.57 (d, J = 2.0 Hz, 1H, H7 in 21f), 8.51-8.49 
(m, 2H, H4 in 22f, H5 in 21f), 8.39 (dd, J = 8.5, 2.0 Hz, 1H, H6 in 22f), 7.98 (d, J = 8.5 Hz, 
1H, H7 in 22f), 7.84 (d, J = 8.5 Hz, 1H, H4 in 21f), 5.06-5.00 (m, 2H, CH in 21f, CH in 22f), 
4.79-4.68 (m, 4H, H3 in 21f, H3 in 22f), 1.65 (d, J = 7.5 Hz, 3H, CH3 in 22f), 1.64 (d, J = 7.5 
Hz, 3H, CH3 in 21f); 13C NMR (175 MHz, CD3OD) δC 174.62 (COOH in 21f or 22f), 174.56 
(COOH in 21f or 22f), 168.8 (C1 in 21f or 22f), 168.7 (C1 in 21f or 22f), 151.8 (C5 in 22f), 
149.82 (C3a or C6 in 21f), 149.78 (C3a or C6 in 21f), 144.9 (C3a in 22f), 138.4 (C7a in 22f), 
134.7 (C7a in 21f), 127.8 (C5 in 21f), 126.0 (C4 in 21f), 125.4 (C7 in 22f), 124.7 (C6 in 22f), 
120.1 (C4 in 22f), 119.5 (C7 in 21f), 51.6 (CH in 21f or 22f), 51.4 (CH in 21f or 22f), 48.7 
(2C, C3 in 21f, C3 in 22f), 15.9 (2C, CH3 in 21f, CH3 in 22f); HRMS (ASAP+) m/z 
calculated for C11H11N2O5 [M+H]: 251.0668; found: 251.0662. See SI2 for 1H and 13C NMR 
spectra. 
2-(4,6-Dimethoxy-1-oxoisoindolin-2-yl)propanoic acid (28) with 2-(5,7-dimethoxy-1-
oxoisoindolin-2-yl)propanoic acid (29)  
Small scale condensation reaction at reflux: A mixture of 28 and 29 was synthesised 
according to general procedure B using 3,5-dimethoxyphthalaldehyde (27, 1.0 equiv., 30 mg, 
0.15 mmol) and alanine (16, 1.2 equiv., 17 mg, 0.19 mmol). A pure regioisomeric mixture of 
28 and 29 was obtained as a yellow gum (37 mg, 0.14 mmol, 93%). 
Small scale condensation reaction at rt: To a solution of 3,5-dimethoxyphthalaldehyde (27, 
1.0 equiv., 30 mg, 0.15 mmol) in anhydrous MeCN (0.55 mL) was added alanine (16, 1.2 
equiv., 17 mg, 0.19 mmol) under a nitrogen atmosphere. The reaction was stirred at rt for 29 
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h before being concentrated in vacuo to afford the crude mixture of regioisomers. A 
quantitative 1H NMR spectrum was acquired on this crude reaction mixture and processed as 
explained in general procedure B. A pure regioisomeric mixture of 28 and 29 was then 
obtained after purification by column chromatography (0‒10% MeOH in DCM then 0‒10% 
MeOH in DCM with 1% CH3COOH) as a yellow gum (40 mg, 0.15 mmol, quant.). 
Gram-scale condensation reaction at reflux: A mixture of 28 and 29 was synthesised 
according to general procedure B using 3,5-dimethoxyphthalaldehyde (27, 1.0 equiv., 0.97 g, 
5.0 mmol) and alanine (16, 1.2 equiv., 0.53 g, 6.0 mmol). A pure regioisomeric mixture of 28 
and 29 was obtained as a yellow gum (1.20 g, 4.52 mmol, 90%).  
The 1H and 13C NMR signals integration are given assuming a mixture of 28:29 with a ratio 
of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2922 (O-H stretch), 1732 (C=O stretch), 1601 (br. C=O stretch), 
1504 (C=C stretch), 1456 (O-H bend), 1202 (C-O stretch), 1146 (C-O stretch), 772; 1H NMR 
(700 MHz, CD3OD) δH 6.88 (d, J = 2.0 Hz, 1H, H7 in 28), 6.74 (d, J = 2.0 Hz, 1H, H5 in 28), 
6.69 (d, J = 2.0 Hz, 1H, H4 in 29), 6.52 (d, J = 2.0 Hz, 1H, H6 in 29), 4.97 (q, J = 7.5 Hz, 2H, 
CH in 28, CH in 29), 4.49 (d, J = 17.0 Hz, 1H, H3 in 29), 4.44 (d, J = 17.0 Hz, 1H, H3 in 28), 
4.42 (d, J = 17.0 Hz, 1H, H3 in 29), 4.39 (d, J = 17.0 Hz, 1H, H3 in 28), 3.89 (s, 3H, H1’ in 
28), 3.88 (s, 3H, H1’ in 29), 3.87 (s, 3H, H1’’ in 29), 3.85 (s, 3H, H1’’ in 28), 1.60 (d, J = 7.5 
Hz, 3H, CH3 in 28), 1.57 (d, J = 7.5 Hz, 3H, CH3 in 29); 13C NMR (175 MHz, CD3OD) δC 
174.7 (2C, COOH in 28, COOH in 29), 171.0 (C1 in 28), 170.0 (C1 in 29), 166.6 (C5 in 29), 
163.5 (C6 in 28), 159.8 (C7 in 29), 156.9 (C4 in 28), 148.3 (C3a in 29), 135.0 (C7a in 28), 
124.3 (C3a in 28), 113.3 (C7a in 29), 103.5 (C5 in 28), 100.5 (C4 in 29), 99.1 (C6 in 29), 
98.8 (C7 in 28), 56.3 (C1’ or C1’’ in 29), 56.23 (C1’ or C1’’ in 28), 56.17 (C1’ or C1’’ in 
28), 56.0 (C1’ or C1’’ in 29), 51.2 (CH in 28), 50.5 (CH in 29), 48.1 (C3 in 29), 46.0 (C3 in 
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28), 15.92 (CH3 in 28), 15.88 (CH3 in 29); HRMS (ES+) m/z calculated for C13H15NO5Na 
[M+Na]+: 288.0842; found: 288.0841. See SI2 for 1H and 13C NMR spectra. 
Methyl 2-(4,6-dimethoxy-1-oxoisoindolin-2-yl)propanoate (30) and methyl 2-(5,7-
dimethoxy-1-oxoisoindolin-2-yl)propanoate (31) 
To a solution of 2-(4,6-dimethoxy-1-oxoisoindolin-2-yl)propanoic acid (28) and 2-(5,7-
dimethoxy-1-oxoisoindolin-2-yl)propanoic acid (29) (1 equiv., 1.20 g, 4.52 mmol) in 
anhydrous MeOH (82 mL) was added freshly distilled SOCl2 (8.2 mL) dropwise at 0 °C 
under a nitrogen atmosphere. The reaction was stirred at rt for 12 h under a nitrogen 
atmosphere before being concentrated in vacuo within a fume cupboard. Separation of the 
two isomers 30 and 31 was achieved by column chromatography (0‒100% EtOAc in 
petroleum ether). Pure 30 was obtained as a yellow solid (1.06 g, 3.80 mmol, 84%) and pure 
31 was obtained as an oil (0.20 g, 0.70 mmol, 16%). 
30: Mp: 98‒100 °C; IR νMax cm-1 (Thin Film) 2949 (C-H stretch), 1740 (C=O stretch), 1682 
(C=O stretch), 1605 (C=C stretch), 1503 (C=C stretch), 1329, 1209 (C-O stretch), 1144 (C-O 
stretch), 1110, 1061 (C-O stretch), 1020, 941, 839, 775; 1H NMR (400 MHz, CDCl3) δH 6.94 
(d, J = 2.0 Hz, 1H, H7), 6.59 (d, J = 2.0 Hz, 1H, H5), 5.16 (q, J = 7.5 Hz, 1H, CH), 4.41 (d, J 
= 16.5 Hz, 1H, H3), 4.29 (d, J = 16.5 Hz, 1H, H3), 3.853 (s, 3H, H1’ or H1’’), 3.848 (s, 3H, 
H1’ or H1’’), 3.71 (s, 3H, OCH3), 1.56 (d, J = 7.5 Hz, 3H, CH3); 13C NMR (125 MHz, 
CDCl3) δC 172.4 (C=O), 168.9 (C1), 161.9 (C6), 155.3 (C4), 134.3 (C7a), 123.0 (C3a), 102.7 
(C5), 98.0 (C7), 56.0 (C1’ or C1’’), 55.6 (C1’ or C1’’), 52.6 (OCH3), 49.4 (CH), 44.6 (C3), 
16.0 (CH3); HRMS (ES+) m/z calculated for C14H17NO5Na [M+Na]+: 302.0999; found: 
302.0997. See SI2 for 1H and 13C NMR spectra. 
31: IR νMax cm-1 (Thin Film) 2947 (C-H stretch), 1738 (C=O stretch), 1678 (C=O stretch), 
1603 (C=C stretch), 1452 (C-H bend), 1433 (C-H bend),1327, 1213 (C-O stretch), 1148 (C-O 
stretch), 1076 (C-O stretch), 835; 1H NMR (400 MHz, CDCl3) δH 6.51 (d, J = 1.9 Hz, 1H, 
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H4), 6.41 (d, J = 1.9 Hz, 1H, H6), 5.12 (q, J = 7.4 Hz, 1H, CH), 4.45 (d, J = 16.6 Hz, 1H, 
H3), 4.30 (d, J = 16.6 Hz, 1H, H3), 3.91 (s, 3H, H1’), 3.85 (s, 3H, H1’’), 3.69 (s, 3H, OCH3), 
1.52 (d, J = 7.4 Hz, 3H, CH3); 13C NMR (175 MHz, CDCl3) δC 172.8 (C=O), 167.6 (C1), 
164.6 (C5), 158.7 (C7), 146.4 (C3a), 113.1 (C7a), 99.2 (C4), 98.3 (C6), 56.0 (C1’ or C1’’), 
55.9 (C1’ or C1’’), 52.4 (OCH3), 48.9 (CH), 46.7 (C3), 15.9 (CH3); HRMS (ASAP+) m/z 
calculated for C14H18NO5 [M+H]: 280.1185; found: 280.1182. See SI2 for 1H and 13C NMR 
spectra. 
(2-(Hydroxymethyl)-3-methoxyphenyl)methan-d2-ol (42) 
42 was synthesised according to general procedure C using 4-methoxyisobenzofuran-1(3H)-
one (40, 1 equiv., 2.00 g, 12.2 mmol), NaBD4 (2 equiv., 1.02 g, 24.4 mmol), ZnCl2 (1 equiv., 
1.66 g, 12.2 mmol) and N,N-dimethylaniline (1 equiv., 1.55 mL, 12.2 mmol). Pure 42 was 
obtained as a white solid (1.29 g, 7.6 mmol, 62%). The small intensity of the CD2 carbon on 
the 13C NMR spectrum revealed a multiplet. 
Mp: 92‒94 °C; IR νMax cm-1 (Thin Film) 3256 (O-H stretch), 1584 (C=C stretch), 1472 (O-H 
bend), 1261 (C-O stretch), 1186, 1094, 1042 (C-O stretch), 1007, 982, 775;  1H NMR (500 
MHz, CDCl3) δH 7.29-7.26 (m, 1H, H5), 6.97 (d, J = 7.5 Hz, 1H, H6), 6.90 (d, J = 8.5 Hz, 
1H, H4), 4.84 (s, 2H, H1’’), 3.86 (s, 3H, OCH3); 13C NMR (125 MHz, CDCl3) δC 158.0 (C3), 
141.1 (C1), 129.4 (C5), 127.8 (C2), 122.0 (C6), 111.0 (C4), 63.8-63.2 (m, C1’), 56.4 (C1’’), 
55.9 (OCH3); HRMS (ES+) m/z calculated for C9H10O32H2Na [M+Na]+: 193.0804; found: 
193.0803. See SI2 for 1H and 13C NMR spectra. 
2-(Formyl-d)-6-methoxybenzaldehyde (35) 
35 was synthesised according to general procedure A using (2-(hydroxymethyl)-3-
methoxyphenyl)methan-d2-ol (42, 1.0 equiv., 200 mg, 1.18 mmol), (COCl)2 (2.6 equiv., 0.26 
mL, 3.06 mmol), DMSO (5.2 equiv., 0.44 mL, 6.14 mmol). Additional DMSO (0.3 mL) was 
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required to help 42 solubilisation. The reaction was stirred at rt for 17 h. Pure 35 was 
obtained as a yellow solid (130 mg, 0.79 mmol, 67%).  
Mp: 78‒81 °C; IR νMax cm-1 (Thin Film) 2928 (C-H stretch), 1674 (C=O stretch), 1582 (C=C 
stretch), 1472 (C-H bend), 1271 (C-O stretch), 1090, 1028 (C-O stretch), 795;  1H NMR (500 
MHz, CDCl3) δH 10.64 (s, 1H, CHO), 7.66-7.63 (m, 1H, H5), 7.45 (d, J = 7.5 Hz, 1H, H6), 
7.24 (d, J = 8.5 Hz, 1H, H4), 3.98 (s, 3H, OCH3); 13C NMR (125 MHz, CDCl3) δC 192.6 (t, J 
= 28.8 Hz, CDO), 191.4 (CHO), 162.0 (C3), 138.6 (t, J = 3.7 Hz, C1), 135.4 (C5), 125.1 
(C2), 120.3 (C6), 116.3 (C4), 56.4 (OCH3); HRMS (ES+) m/z calculated for C9H7O32HNa 
[M+Na]+: 188.0428; found: 188.0429. See SI2 for 1H and 13C NMR spectra. 
2-(4-Methoxy-1-oxoisoindolin-2-yl)propanoic acid (18a) with 2-(7-methoxy-1-
oxoisoindolin-2-yl-3-d)propanoic acid (19a’) 
A mixture of 18a and 19a’ was synthesised according to general procedure B using 2-
(formyl-d)-6-methoxybenzaldehyde (35, 1.0 equiv., 30 mg, 0.18 mmol) and alanine (16, 1.2 
equiv., 19 mg, 0.22 mmol). A pure regioisomeric mixture of 18a and 19a’ was obtained as a 
light yellow solid (26 mg, 0.11 mmol, 61%). The 1H and 13C NMR signals integration are 
given assuming a mixture of 18a:19a’ with a ratio of 1:1 for clarity. 
IR νMax cm-1 (Thin Film) 2920 (O-H stretch), 2359 (C-H stretch), 1734 (C=O stretch), 1624 
(C=O stretch), 1605 (C=C stretch), 1558 (C=C stretch), 1497 (C-H bend), 1489 (C-H bend), 
1456 (O-H bend), 1273 (C-O stretch), 1192, 1061 (C-O stretch); 1H NMR (700 MHz, 
CD3OD) δH 7.54 (t, J = 8.0 Hz, 1H, H5 in 19a’), 7.47 (t, J = 8.0 Hz, 1H, H6 in 18a), 7.36 (d, 
J = 8.0 Hz, 1H, H7 in 18a), 7.18 (d, J = 8.0 Hz, 1H, H5 in 18a), 7.10 (d, J = 8.0 Hz, 1H, H4 
in 19a’), 7.01 (d, J = 8.0 Hz, 1H, H6 in 19a’), 4.98 (q, J = 7.5 Hz, 2H, CH in 18a, CH in 
19a’), 4.54-4.45 (m, 3H, H3 in 18a, H3 in 19a’), 3.93 (s, 3H, OCH3 in 18a), 3.91 (s, 3H, 
OCH3 in 19a’), 1.61 (d, J = 7.5 Hz, 3H, CH3 in 18a), 1.58 (d, J = 7.5 Hz, 3H, CH3 in 19a’); 
13C NMR (175 MHz, CD3OD) δC 175.2 (COOH in 19a’), 175.0 (COOH in 18a), 171.0 (C1 
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in 18a), 170.0 (C1 in 19a’), 158.8 (C7 in 19a’), 156.2 (C4 in 18a), 146.3 (C3a in 19a’), 135.0 
(C5 in 19a’), 134.5 (C7a in 18a), 131.4 (C3a in 18a), 131.1 (C6 in 18a), 120.1 (C7a in 19a’), 
116.3 (C4 in 19a’), 116.2 (C7 in 18a), 114.5 (C5 in 18a), 111.2 (C6 in 19a’), 56.1 (OCH3 in 
18a), 56.0 (OCH3 in 19a’), 51.2 (CH in 18a), 50.8 (CH in 19a’), 47.7 (t, J = 21.6 Hz, C3 in 
19a’), 46.3 (C3 in 18a), 16.0 (CH3 in 18a), 15.9 (CH3 in 19a’); HRMS (ES-) m/z calculated 
for C12H112H1NO4 [M-H]-: 235.0835; found: 235.0829 for 19a’; m/z calculated for 
C12H12NO4 [M-H]-: 234.0772; found: 234.0773 for 18a. See SI2 for 1H and 13C NMR spectra. 
(2-(Hydroxymethyl)-6-methoxyphenyl)methan-d2-ol (43) 
43 was synthesised according to general procedure C using 7-methoxyisobenzofuran-1(3H)-
one (41, 1 equiv., 145 mg, 0.88 mmol), NaBD4 (2 equiv., 74 mg, 1.77 mmol), ZnCl2 (1 
equiv., 120 mg, 0.88 mmol) and N,N-dimethylaniline (1 equiv., 0.11 mL, 0.88 mmol). 
Additional THF (1 mL) was required to help 41 solubilisation. Pure 43 was obtained as a 
white gum (73 mg, 0.43 mmol, 49%). The small intensity of the CD2 carbon on the 13C NMR 
spectrum revealed a multiplet.  
IR νMax cm-1 (Thin Film) 3248 (O-H stretch), 1584 (C=C stretch), 1470 (O-H bend), 1449 (C-
H bend), 1439 (C-H bend), 1260 (C-O stretch), 1086, 1038 (C-O stretch), 959, 783;  1H 
NMR (500 MHz, CD3OD) δH 7.27 (t, J = 8.0 Hz, 1H, H5), 7.02 (d, J = 8.0 Hz, 1H, H6), 6.94 
(d, J = 8.0 Hz, 1H, H4), 4.72 (s, 2H, H1’), 3.83 (s, 3H, CH3); 13C NMR (125 MHz, CD3OD) 
δC 159.3 (C3), 142.7 (C1), 130.1 (C5), 127.8 (C2), 121.8 (C6), 111.3 (C4), 63.2 (C1’), 56.1 
(CH3), 55.5-54.8 (m, C1’’); HRMS (ES+) m/z calculated for C9H10O32H2Na [M+Na]+: 
193.0804; found: 193.0801. See SI2 for 1H and 13C NMR spectra. 
2-(Formyl-d)-3-methoxybenzaldehyde (39)  
39 was synthesised according to general procedure A using (2-(hydroxymethyl)-6-
methoxyphenyl)methan-d2-ol (45, 1.0 equiv., 50 mg, 0.29 mmol), (COCl)2 (2.6 equiv., 0.07 
mL, 0.76 mmol), DMSO (5.2 equiv., 0.11 mL, 1.51 mmol). Additional DMSO (0.1 mL) was 
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required to help 43 solubilisation. The reaction was stirred at rt for 15 h. Pure 39 was 
obtained as a light yellow gum (42 mg, 0.25 mmol, 86%).  
IR νMax cm-1 (Thin Film) 2924 (C-H stretch), 1697 (C=O stretch), 1657 (C=O stretch), 1607 
(C=C stretch), 1584 (C=C stretch), 1487 (C-H bend), 1472 (C-H bend), 1437 (C-H bend), 
1269 (C-O stretch), 1242 (C-O stretch), 1067, 966, 916, 868, 768; 1H NMR (700 MHz, 
CDCl3) δH 10.42 (s, 1H, CHO), 7.62 (t, J = 8.0 Hz, 1H, H5), 7.42 (d, J = 8.0 Hz, 1H, H6), 
7.22 (d, J = 8.0 Hz, 1H, H4), 3.95 (s, 3H, OCH3); 13C NMR (175 MHz, CDCl3) δC 192.9 
(CHO), 191.4-190.9 (m*, CDO), 162.0 (C3), 138.7 (C1), 135.4 (C5), 124.9 (C2), 120.2 (C6), 
116.3 (C4), 56.4 (OCH3).The rapid decomposition of 41 prevented mass spectrometric 
analysis. *Multiplet signal consistent with potential traces of undeuterated 17a. See SI2 for 
1H and 13C NMR spectra. 
2-(4-Methoxy-1-oxoisoindolin-2-yl-3-d)propanoic acid (18a’) with 2-(7-methoxy-1-
oxoisoindolin-2-yl)propanoic acid (19a) and with traces of 2-(4-methoxy-1-
oxoisoindolin-2-yl)propanoic acid (18a) 
A mixture of 18a’ and 19a with traces of 18a was synthesised according to general procedure 
B using 2-(formyl-d)-3-methoxybenzaldehyde (39, 1.0 equiv., 42 mg, 0.25 mmol) and 
alanine (16, 1.2 equiv., 27 mg, 0.31 mmol). A pure regioisomeric mixture of 18a’ and 19a 
with traces of 18a was obtained as a brown solid (46 mg, 0.20 mmol, 80%). The 1H and 13C 
NMR signals integration are given assuming a mixture 18a:18a’:19a with a ratio of 1:1:1 for 
clarity. 
IR νMax cm-1 (Thin Film) 2922 (O-H bend), 2359 (C-H stretch), 1734 (C=O stretch), 1636 
(C=O stretch), 1603 (C=C stretch), 1491 (C-H bend), 1418 (O-H bend), 1269 (C-O stretch), 
1065 (C-O stretch), 953; 1H NMR (700 MHz, CD3OD) δH 7.51 (t, J = 8.0 Hz, 1H, H5 in 
19a), 7.44 (t, J = 8.0 Hz, 2H, H6 in 18a, H6 in 18a’), 7.34 (d, J = 8.0 Hz, 2H, H7 in 18a, H7 
in 18a’), 7.15 (d, J = 8.0 Hz, 2H, H5 in 18a, H5 in 18a’), 7.08 (d, J = 8.0 Hz, 1H, H4 in 19a), 
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6.98 (d, J = 8.0 Hz, 1H, H6 in 19a), 4.96-4.89 (m, 3H, CH in 18a, CH in 18a’, CH in 19a), 
4.56-4.41 (m, 5H, H3 in 18a, H3 in 18a’, H3 in 19a), 3.90 (s, 6H, OCH3 in 18a, OCH3 in 
18a’), 3.89 (s, 3H, OCH3 in 19a), 1.58 (d, J = 7.5 Hz, 6H, CH3 in 18a, CH3 in 18a’), 1.55 (d, 
J = 7.5 Hz, 3H, CH3 in 19a); 13C NMR (175 MHz, CD3OD) δC 176.1 (3C, COOH in 18a, 
COOH in 18a’, COOH in 19a), 171.0 (2C, C1 in 18a, C1 in 18a’), 169.9 (C1 in 19a), 158.6 
(C7 in 19a), 156.1 (2C, C4 in 18a, C4 in 18a’), 146.3 (C3a in 19a), 134.8 (C5 in 19a), 134.7 
(2C, C7a in 18a, C7a in 18a’), 131.4 (2C, C3a in 18a, C3a in 18a’), 131.0 (2C, C6 in 18a, C6 
in 18a'), 120.2 (C7a in 19a), 116.23 (C4 in 19a), 116.15 (2C, C7 in 18a, C7 in 18a’), 114.4 
(2C, C5 in 18a, C5 in 18a’), 111.1 (C6 in 19a), 56.1 (2C, OCH3 in 18a, OCH3 in 18a’), 56.0 
(OCH3 in 19a), 51.8 (2C, CH in 18a, 1C, CH in 18a’), 51.3 (CH in 19a), 48.0 (C3 in 19a), 
46.4 (C3 in 18a), 46.1 (t, J = 21.5 Hz, C3 in 18a’), 16.2 (2C, CH3 in 18a, CH3 in 18a’), 16.1 
(CH3 in 19a); HRMS (ES-) m/z calculated for C12H112H1NO4 [M-H]-: 235.0835; found: 
235.0834 for 18a’; m/z calculated for C12H12NO4 [M-H]-: 234.0772; found: 234.0775 for 18a 
and 19a. See SI2 for 1H and 13C NMR spectra. 
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